Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Graham

Showing results (1341-1350 of 1,460) with videos related to

Pageof 146
Sort By:
Human Vaccines & Immunotherapeutics|May 29, 2012
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse eventsClaudia Schmidt, Carol Smith, Burc Barin, et al.
Science (New York, N.Y.)|November 2, 2013
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virusJason S McLellan, Man Chen, M Gordon Joyce, et al.
The New England Journal of Medicine|November 27, 2014
Chimpanzee Adenovirus Vector Ebola VaccineJulie E Ledgerwood, Adam D DeZure, Daphne A Stanley, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challengeMichelle Meyer, Yuan Wang, Darin Edwards, et al.
Plos Medicine|January 25, 2018
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adultsMartin R Gaudinski, Emily E Coates, Katherine V Houser, et al.
The Journal of Infectious Diseases|October 18, 2015
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083Stephen R Walsh, Zoe Moodie, Andrew J Fiore-Gartland, et al.
Nature Communications|July 29, 2015
Evaluation of candidate vaccine approaches for MERS-CoVLingshu Wang, Wei Shi, M Gordon Joyce, et al.
The Journal of Infectious Diseases|April 16, 2022
Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient PatientSjanna B Besteman, Emily Phung, Henriette H M Raeven, et al.
Plos One|September 30, 2010
Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in AfricaWalter Jaoko, Etienne Karita, Kayitesi Kayitenkore, et al.
Gut|September 7, 2021
Diet quality and risk and severity of COVID-19: a prospective cohort studyJordi Merino, Amit D Joshi, Long H Nguyen, et al.
Pageof 146

Showing results (1341-1350 of 1,460) with videos related to

Sort By:
Pageof 146
Human Vaccines & Immunotherapeutics|May 29, 2012
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse eventsClaudia Schmidt, Carol Smith, Burc Barin, et al.
Science (New York, N.Y.)|November 2, 2013
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virusJason S McLellan, Man Chen, M Gordon Joyce, et al.
The New England Journal of Medicine|November 27, 2014
Chimpanzee Adenovirus Vector Ebola VaccineJulie E Ledgerwood, Adam D DeZure, Daphne A Stanley, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challengeMichelle Meyer, Yuan Wang, Darin Edwards, et al.
Plos Medicine|January 25, 2018
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adultsMartin R Gaudinski, Emily E Coates, Katherine V Houser, et al.
The Journal of Infectious Diseases|October 18, 2015
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083Stephen R Walsh, Zoe Moodie, Andrew J Fiore-Gartland, et al.
Nature Communications|July 29, 2015
Evaluation of candidate vaccine approaches for MERS-CoVLingshu Wang, Wei Shi, M Gordon Joyce, et al.
The Journal of Infectious Diseases|April 16, 2022
Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient PatientSjanna B Besteman, Emily Phung, Henriette H M Raeven, et al.
Plos One|September 30, 2010
Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in AfricaWalter Jaoko, Etienne Karita, Kayitesi Kayitenkore, et al.
Gut|September 7, 2021
Diet quality and risk and severity of COVID-19: a prospective cohort studyJordi Merino, Amit D Joshi, Long H Nguyen, et al.
Pageof 146